Cells isolated from human glioblastoma multiforme express progesterone-induced blocking factor (PIBF)

Cellular and Molecular Neurobiology

Volumn 34, Issue 4, 2014, Pages 479-489

  Kyurkchiev, Dobroslav ^a   Naydenov, Emanuil ^a   Tumangelova Yuzeir, Kalina ^a   Ivanova Todorova, Ekaterina ^a   Belemezova, Kalina ^b   Bochev, Ivan ^c   Minkin, Krasimir ^a   Mourdjeva, Milena ^d   Velikova, Tsvetelina ^a   Nachev, Sevdalin ^a   Kyurkchiev, Stanimir ^b,c  

^a UNIVERSITY HOSPITAL ST IVAN RILSKI   (Bulgaria)

^b Tissue bank BULGEN   (Bulgaria)

^c University Hospital of Obstetrics and Gynecology 'Maichin Dom' Bulgaria   (Bulgaria)

^d BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

Author keywords

Cancer stem cells; Glioblastoma multiforme; Immunosuppression; Progesterone induced blocking factor

Indexed keywords

MESSENGER RNA; PIBF1 PROTEIN, HUMAN; PLACENTA PROTEIN; PROGESTERONE; SUPPRESSOR FACTOR;

CANCER STEM CELL; CELL SEPARATION; CYTOLOGY; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PROCEDURES; TUMOR CELL CULTURE;

CELL SEPARATION; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASTIC STEM CELLS; PREGNANCY PROTEINS; PROGESTERONE; RNA, MESSENGER; SUPPRESSOR FACTORS, IMMUNOLOGIC; TUMOR CELLS, CULTURED;

EID: 84898916430     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-014-0031-3     Document Type: Article

References (61)

1. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, Aigner L, Brawanski A, Bogdahn U, Beier CP (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67:4010-4015
2. Beier CP, Kumar P, Meyer K, Leukel P, Bruttel V, Aschenbrenner I, Riemenschneider MJ, Fragoulis A, Rummele P, Lamszus K, Schulz JB, Weis J, Bogdahn U, Wischhusen J, Hau P, Spang R, Beier D (2012) The cancer stem cell subtype determines immune infiltration of glioblastoma. Stem Cells Dev 21:2753-2761
3. Borel I, Gentile T, Angelucci J, Margni R, Binaghi R (1989) Asymmetrically glycosylated IgG isolated from non-immune human sera. Biochim Biophys Acta 24:162-164
4. Bouffi C, Bony C, Courties G, Jorgensen C, Noël D (2010) IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS ONE 5:1-12
5. Brescia P, Ortensi B, Fornasari L, Levi D, Broggi G, Pelicci G (2013) CD133 is essential for glioblastoma stem cell maintenance. Stem Cells 31:857-869
6. Caballero O, de Souza S, Brentani R, Simpson A (2001) Alternative spliced transcripts as cancer markers. Dis Markers 17:67-75
7. Caldera V, Mellai M, Annovazzi L, Piazzi A, Lanotte M, Cassoni P, Schiffer D (2011) Antigenic and genotypic similarity between primary glioblastomas and their derived neurospheres. J Oncol. doi: 10.1155/2011/314962
8. Check JH, Nazari P, Goldberg J, Yuen W, Angotti D (2001) A model for potential tumor immunotherapy based on knowledge of immune mechanisms responsible for spontaneous abortion. Med Hypotheses 57:337-343
9. Check JH, Sansoucie L, Chern J, Amadi N, Srivastava M, Larece K (2007) Evidence that progesterone receptor antagonists may help in the treatment of a variety of cancers by locally suppressing natural killer cell activity. Clin Exp Obstet Gynecol 34:207-211
10. Check JH, Dix E, Sansoucie L (2009) Support for the hypothesis that successful immunotherapy of various cancers can be achieved by inhibiting a progesterone associated immunomodulatory protein. Med Hypotheses 72:87-90
11. Check JH, Sansoucie L, Chern J, Dix E (2010) Mifepristone treatment improves length and quality of survival of mice with spontaneous lung cancer. Anticancer Res 30:119-122
12. Cho DY, Lin SZ, Yang WK, Lee HC, Hsu DM, Lin HL, Chen CC, Liu CL, Lee WY, Ho LH (2013) Targeting cancer stem cells for treatment of glioblastoma multiforme. Cell Transplant 22:731-739
13. Di Tomaso T, Mazzoleni S, Wang E, Sovena G, Clavenna D, Franzin A, Mortini P, Ferrone S, Doglioni C, Marincola FM, Galli R, Parmiani G, Maccali C (2010) Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin Cancer Res 16:800-813
14. Dimov I, Tasic-Dimov D, Conic I, Stefanovic V (2010) Glioblastoma multiforme stem cells. Sci World J 11:930-958
15. Doetsch F, Petreanu L, Caille I, Garcia-Verdugo J-M, Alvarez-Buylla A (2002) EGF converts transit-amplifying neurogenic precursors in the adults brain into multipotent stem cells. Neuron 36:1021-1034
16. Facchino S, Abdouh M, Bernier G (2011) Brain cancer stem cells: current status on glioblastoma multiforme. Cancers 3:1777-1797
17. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, Vescovi A (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:7011-7021
18. Gilbert CA, Ross AH (2009) Cancer stem cells: cell culture, markers, and targets for new therapies. J Cell Biochem 108:1031-1038
19. Gilbert C, Ross A (2011) Glioma stem cells: cell culture, markers and targets for new combination therapies. In: Shostak S (ed) Cancer stem cells theories and practice. Intech Publisher, Croatia, pp 79-105
20. Günther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, Modrusan Z, Meissner H, Westphal M, Lamszus K (2008) Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 27:2897-2909
21. Gürsel DB, Shin BJ, Burkhardt JK, Kesavabhotla K, Schlaff CD, Boockvar JA (2011) Glioblastoma stem-like cells-biology and therapeutic implications. Cancers (Basel) 3:2655-2666
22. Gustafson MP, Lin Y, New KC, Bulur PA, O'Neill BP, Gastineau DA, Dietz AB (2010) Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro Oncol 12:631-644
23. Halasz M, Polgar B, Berta G, Czimbalek L, Szekeres-Bartho J (2013) Progesterone-induced blocking factor differentially regulates trophoblast and tumor invasion by altering matrix metalloproteinase activity. Cell Mol Life Sci 70:4617-4630
24. Hong X, Chedid K, Kalkanis SN (2012) Glioblastoma cell line-derived spheres in serumcontaining medium versus serum-free medium: a comparison of cancer stem cell properties. Int J Oncol 41:1693-1700
25. Ivanova-Todorova E, Kyurkchiev DS, Nalbanski A, Timeva T, Shterev A, Kyurkchiev SD (2008) Production and characterization of a novel monoclonal antibody against progesterone-induced blocking factor (PIBF). J Reprod Immunol 78:94-101
26. Ivanova-Todorova E, Mourdjeva M, Kyurkchiev D, Bochev I, Stoyanova E, Dimitrov R, Timeva T, Yunakova M, Bukarev D, Shterev A, Tivchev P, Kyurkchiev S (2009) HLA-G expression is up-regulated by progesterone in mesenchymal stem cells. Am J Reprod Immunol 62:25-33
27. Ivanova-Todorova E, Bochev I, Dimnitrov R, Belemezova K, Mourdjeva M, Kyurkchiev S, Kinov P, Altankova I, Kyurkchiev D (2012) Conditioned medium from adipose tissue derived mesenchymal stem cells induces CD4+ FoxP3+ cells and increases IL-10 secretion. J Biomed Biotechnol 2012:1-8
28. Kelemen K, Bognar I, Paal M, Szekeres-Bartho J (1996) A progesterone-induced protein increases the synthesis of asymmetric antibodies. Cell Immunol 167:129-134
29. Kim K, Rhee K (2011) The pericentriolar satellite protein CEP90 is crucial for integrity of the mitotic spindle pole. J Cell Sci 124:338-347
30. Kondo T, Setoguchi T, Taga T (2004) Persistance of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. PNAS 101:781-786
31. Kozma N, Halasz M, Polgar B, Poehlmann T, Markret U, Palkovics T, Keszei M, Par G, Kiss K, Szebereyi J, Grama L, Szekerez-Bartho J (2006) Progesterone-induced blocking factor activates STAT6 via binding to a novel IL-4 receptor. J Immunol 176:819-826
32. Kyurkchiev D, Ivanova-Todorova E, Kyurkchiev S (2011) Effect of progesterone on human mesenchymal stem cells, vol 87. Academic Press, Burlington, pp 217-234
33. Kyurkchiev D, Ivanova-Todorova E, Bochev I, Mourdjeva M, Kyurkchiev S (2013) Differences between adipose tissue derived mesenchymal stem cells and bone marrow derived mesenchymal stem cells as regulator of the immune response. Stem Cells Cancer Stem Cells 10:71-84
34. Lachmann M, Gelbmann D, Kalman E, Polgar B, Buschle M, Von Gabain A, Szekeres-Bartho J, Nagy E (2004) PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome. Int J Cancer 112:51-60
35. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W et al (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391-403
36. Mao P, Joshi K, Li J, Kim SH, Li P, Santana-Santos L, Luthra S, Chandran UR, Benos PV, Smith L et al (2013) Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc Natl Acad Sci USA 110:8644-8649
37. Matsuda Y, Yoshimura H, Suzuki T, Ishiwata T (2013) Nestin: neural stem/progenitor cell marker in brain tumors. In: Lichtor T (ed) Evolution of the molecular biology of brain tumors and the therapeutic implications. InTech, Croatia, pp 623-638
38. McLendon RE, Rich JN (2011) Glioblastoma stem cells: a neuropathologist's view. J Oncol. doi: 10.1155/2011/397195
39. Miko E, Halasz M, Jericevic-Mulac B, Wicherek L, Arck P, Arato G, Skret Magierlo J, Rukavina D, Szekeres-Bartho J (2011) Progesterone-induced blocking factor (PIBF) and trophoblast invasiveness. J Reprod Immunol 90:50-57
40. Motaln H, Gruden K, Hren M, Schichor C, Primon M, Rotter A, Lah TT (2011) Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma. Cell Transplant 21:1529-1545
41. Nakagawa T, Tsuruoka M, Ogura H, Okuyama Y, Arima Y, Hirano T, Murakami M (2009) IL-6 positively regulates Foxp3+ CD8+ T cells in vivo. Int Immunol 22:129-139
42. Nakahata AM, Suzuki DE, Rodini CO, Pereira MC, Janjoppi L, Okamoto OK (2011) Human glioblastoma cells display mesenchymal stem cell features and form intracranial tumors in immunocompetent rats. J Stem Cells 5:103-111
43. Pavon LF, Marti LC, Sibov TT, Miyaki LA, Malheiros SM, Mamani JB, Brandt RA, Ribas GC, Pagura JR, Joaquim MA, Feres Junior H, Gamarra LF (2012) Isolation, cultivation and characterization of CD133+ stem cells from human glioblastoma. Einstein (Sao Paulo) 10:197-202
44. Piccirillo S, Dietz S, Madhu B, Griffiths J, Price SJ, Collins VP, Watts C (2012) Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiatingcell populations in the tumour mass and margin. Cancer Res 107:462-468
45. Piperi C, Zisakis A, Lea RW, Kalofoutis A (2005) Role of cytokines in the regulation of glioma tumour growth and angiogenesis. Am J Immunol 1:106-113
46. Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-Shamali E (1999) Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 196:122-130
47. Rozenblum E, Vahteristo P, Sandberg T, Bergthorsson J, Syrjakoski K, Weaver D, Haraldsson K, Johannsdottir H, Vehmanen P, Nigam S et al (2002) A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes. Hum Genet 110:111-121
48. Sanai N, Alvarez-Buylla A, Berger M (2005) Neural stem cells and origin of gliomas. N Engl J Med 353:811-822
49. Schiffer D, Mellai M, Annovazzi L, Piazzi A, Monzeglio O, Caldera V (2010) On the origin and growth of gliomas. Anticancer Res 30:1977-1998
50. Schiffer D, Mellai M, Annovazzi L, Piazzi A, Monzeglio O, Caldera V (2012) Glioblastoma cancer stem cells: basis for a functional hypothesis. Stem Cell Discov 2:122-131
51. Singh S, Hawkins C, Clarke I, Squire J, Bayani J, Hide T, Henkelman R, Cusimano M, Dirks P (2004) Identification of human brain tumour initiating cells. Nature 432:396-401
52. Srivastava MD, Thomas A, Srivastava BI, Check JH (2007) Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. Leuk Lymphoma 48:1610-1617
53. Szekeres-Bartho J, Polgar B (2010) PIBF: the double edged sword. Pregnancy and tumor. Am J Reprod Immunol 64:77-86
54. Szekeres-Bartho J, Wegmann TG (1996) A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 31:81-95
55. Szekeres-Bartho J, Kilar F, Falkay G, Csernus V, Torok A, Pacsa A (1985) The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: I. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis. Am J Reprod Immunol Microbiol 9:15-18
56. Szekeres-Bartho J, Par G, Dombay G, Smart YC, Volgyi Z (1997a) The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity. Cell Immunol 177:194-199
57. Szekeres-Bartho J, Par G, Szereday L, Smart CY, Achatz I (1997b) Progesterone and non-specific immunologic mechanisms in pregnancy. Am J Reprod Immunol 38:176-182
58. Verschuere T, Vleeschouwer S, Lefranc F, Kiss R, Van Gool S (2011) Galectin-1 and immunotherapyfor brain cancer. Expert Rev Neurother 11:533-543
59. Veselska R, Kuglik P, Cejpek P, Svachova H, Neradil J, Loja T, Relichova J (2006) Nestin expression in the cell lines derived from glioblastoma multiforme. BMC Cancer 6:32
60. Villa A, Rubio F, Navarro B, Bueno C, Martinez-Serrano A (2001) Human neural stem cells in vitro. A focus on their isolation and perpetuation. Biomed Pharmacother 55:91-95
61. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL, Black KL, Yu JS (2004) Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23:9392-9400